The content on this site is intended for healthcare professionals only
Dr Fields discusses the ongoing successful collaboration between the Florida Atlantic University and the Memorial Cancer Institute.
The institutes work together on advances in patient treatment, clinical trials, and grant funding, so far securing $4.2 million through collaborative proposals.
Increased collaboration has led to sharing data across more diverse patient populations, and a biorepository has been developed to analyse cancer treatment samples.
Dr Fields is further researching the role of the MBLAC1 protein, enhancing understanding of drug effectiveness and guiding clinical trials.
ASCO 2025: Developments in the treatment of soft tissue sarcoma
Updates on gastrointestinal cancer treatments ASCO 2025
Advancements in gastrointestinal cancer treatments at ASCO 2025
Future of chemotherapy and targeted therapies
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Managing cardiotoxicities for RCC treatment – Cardiologist’s perspective
Understanding Zimbabwe's pharmacovigilance system
Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC
Bone-protective agents given with enzalutamide with or without radium-223 show greater survival benefits in mCRPC
